Managing Psoriasis in a 72-Year-Old Woman through In-Office Biologic Administration
July 7th 2025An expert discusses how treating older patients with psoriasis, such as a 72-year-old retired teacher, requires addressing cognitive decline, dexterity issues, and comorbidities by considering in-office biologic administration and buy-and-bill processes for Medicare accessibility.
Why Treating Scalp Psoriasis With Topicals Remains a Challenge
July 7th 2025Panelists discuss how treating scalp psoriasis remains challenging due to poor compatibility of traditional topicals with hair and scalp characteristics, emphasizing the need for cosmetically acceptable, well-tolerated formulations that improve adherence and reduce premature escalation to systemic therapy.
Escalating to Biologic Therapy in a 5-Year-Old With Severe Atopic Dermatitis
July 7th 2025An expert discusses how a 5-year-old child with severe atopic dermatitis affecting sleep and school performance demonstrates the need for systemic therapy escalation, with dupilumab being an ideal choice given its efficacy for both atopic dermatitis and comorbid asthma.
Prioritizing Rapid Itch Relief in a 58-Year-Old Patient With Severe Prurigo Nodularis
June 30th 2025An expert discusses how to approach a 58-year-old African American woman with severe prurigo nodularis experiencing extreme itch (9/10 rating) and extensive lesions, emphasizing the need for rapid systemic intervention with nemolizumab due to its faster onset of itch relief compared with other biologics.
Challenges With Topical Psoriasis Treatments and the Need for Simpler Options
June 30th 2025Panelists discuss how topical therapies remain essential in psoriasis management across all severities, highlighting the need for simplified, steroid-sparing treatment options that are safe, effective, and easy to use—especially to improve adherence and address patient concerns about adverse effects and complexity.
Personalizing Psoriasis Treatment and Site-of-Care Decisions
June 30th 2025An expert discusses how managing psoriasis requires personalizing treatment based on patient adherence challenges, access issues, comorbidities such as depression, and practical considerations such as injection comfort and frequency.
Exploring the Impact of Itch and Treatment Advances in Prurigo Nodularis
June 30th 2025An expert discusses how prurigo nodularis represents one of the most severe itching conditions in dermatology, significantly impacting patients' quality of life and sleep, and explains the importance of breaking the itch-scratch cycle while highlighting recent treatment advances with targeted biologics like dupilumab and nemolizumab.
Approaches to Personalizing Systemic Treatment in Atopic Dermatitis
June 26th 2025An expert discusses how personalizing systemic atopic dermatitis treatment requires considering factors such as disease severity, patient impact, treatment failures, age, comorbidities, and patient preferences when selecting between biologics and JAK inhibitors.